AI startup grabs $60M, unveils platform aimed at drug discovery's 'data problem'

Amber Tong

As the computational tools for drug discovery proliferate, it can start to feel like an artificial intelligence or machine learning player is entering the fray …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AI startup grabs $60M, unveils platform aimed at drug discovery's 'data problem'

Amber Tong

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

You bet your life: After I was diagnosed with a rare cancer, I discovered how a small band of physician-scientists ...

A VC-backed genetic testing startup to 'consider' making an offer to buy 23andMe

Why did Eli Lilly ask a patient on a compounded GLP-1 drug for their medical information?

In surprise, study suggests Covid mRNA vaccines may boost cancer immunotherapy efficacy

Novo says its CB1 drug helped shed weight, but efficacy and safety questions remain

Breaking down silos with a new quantitative approach to drug development

AI start­up grabs $60M, un­veils plat­form aimed at drug dis­cov­ery's 'da­ta prob­lem'

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

AI startup grabs $60M, unveils platform aimed at drug discovery's 'data problem'